ACAAI

ACAAI Conference Content

featured article image

Novel IL-2 Therapy Shows Promise for Atopic Dermatitis and Asthma in Phase 2b Trial at ACAAI 2025

author

Christos Evangelou, MSc, PhD

Nov 17, 2025

Read Peanut Allergy Study at ACAAI 2025 Reveals Peak Onset Age and Key Risk Factors article image
Christos Evangelou, MSc, PhD Link to Christos Evangelou, MSc, PhD's page

Peanut Allergy Study at ACAAI 2025 Reveals Peak Onset Age and Key Risk Factors

Christos Evangelou, MSc, PhD

Nov 17, 2025 Link to Peanut Allergy Study at ACAAI 2025 Reveals Peak Onset Age and Key Risk Factors